Arbutus Biopharma Corp 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001447028-26-000021
- Form type
- 10-Q
- CIK
- 0001447028
- Primary document
- https://www.sec.gov/Archives/edgar/data/1447028/000144702826000021/abus-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Arbutus Biopharma Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $179.1M | - | - |
| Operating Income | $168.9M | - | - |
| Net Income | $169.7M | - | - |
| Eps Basic | 0.88 | - | - |
| Eps Diluted | 0.87 | - | - |
| Cash And Equivalents | $23.7M | - | - |
| Total Assets | $277.2M | - | - |
| Total Liabilities | $17.0M | - | - |
| Shareholders Equity | $260.2M | - | - |
| Operating Cash Flow | $-8.1M | - | - |